Recent developments in stem cell biology have enabled the study of cell fate decisions in early 29 human development that are impossible to study in vivo. However, understanding how 30 development varies across individuals and, in particular, the influence of common genetic 31 variants during this process has not been characterised. Here, we exploit human iPS cell lines 32 from 125 donors, a pooled experimental design, and single-cell RNA-sequencing to study 33 population variation of endoderm differentiation. We identify molecular markers that are 34 predictive of differentiation efficiency, and utilise heterogeneity in the genetic background 35 across individuals to map hundreds of expression quantitative trait loci that influence 36 expression dynamically during differentiation and across cellular contexts. 37 2
Introduction 38
The early stages of human embryogenesis involve dramatic and dynamic changes in cellular 39
states. However, the extent to which an embryo's genetic background influences this process 40 has only been determined in a small number of special cases linked to rare large-effect 41 variants that cause developmental disorders. This lack of information is critical -it can provide 42 a deep understanding of how genetic heterogeneity is tolerated in normal development, when 43 controlling the expression of key genes is vital. Additionally, with cellular reprogramming 44 becoming an increasingly used tool in molecular medicine, understanding how inter-individual 45 variability effects such differentiations is key. 46 47
Critically, recent technological developments have begun to facilitate such studies in vitro. In 48 particular, the generation of population-scale collections of human induced pluripotent stem 49 cells (iPSCs) [1, 2] has allowed for assessing regulatory genetic variants in pluripotent [1, 2] as 50 well as in differentiated cells [3] [4] [5] . In addition, the rapid developments in single-cell RNA-seq 51 now allow for assessing the molecular impact of genetic variability in a continuous manner 52 across early human development. 53 54
Here, we use a pooled cell differentiation assay to study endoderm differentiation across a set 55 of 125 human iPSC lines, profiling changes in gene expression via single-cell RNA-56 sequencing at 4 developmental timepoints [6] . Our study not only allows discovery of hundreds 57 of novel expression Quantitative Trait Loci (eQTL) that vary across differentiation, but also 58 enables the uncovering of genetic variants that impact the rate at which a cell line 59
differentiates. Finally, we generalise approaches from studies of the interaction between 60 genotype and environment (GxE) by leveraging the single-cell resolution of our study to 61 investigate the interplay between genetic factors and cellular states. 62 98 99 100 
112
Pseudo-temporal ordering yields stage-specific eQTL 113 Motivated by the observation that a substantial fraction of variability in gene expression was 114 explained by cell-line effects (Fig. 1B) , we tested for associations between common genetic 115 variants and gene expression at the three defined stages of cell differentiation (Fig. 1C) . 116 Briefly, for each donor, experimental batch, and differentiation stage, we quantified each 117 gene's average expression level (Methods), before using a linear mixed model to test for cis 118 eQTL, adapting approaches used for bulk RNA-seq profiles (+/-250kb, MAF > 5% [1] ; 119 Methods). In the iPSC population (day0), this identified 1,833 genes with at least one eQTL 120 (denoted eGenes; FDR < 10%; 10,840 genes tested; Table S3 ). To validate our approach, we 121 also performed eQTL mapping using deep bulk RNA-sequencing data from the same set of 122 iPSC lines ("iPSC bulk"; 10,736 genes tested), yielding consistent eQTL (~70% replication of 123 lead eQTL effects; nominal P < 0.05; Methods; Table S4 ). 124 125
Analogously, we mapped eQTL in the mesendo and defendo populations, yielding 1,702 and 126 1,342 eGenes respectively. For comparison, we also performed eQTL mapping in cells 127 collected on day1 and day3 --the experimental time points commonly used to identify cells at 128 mesendo and defendo stages [6] . Interestingly, this approach identified markedly fewer 129 eGenes (1,181 eGenes at day1, and 631 eGenes at day3), demonstrating the power of using 130 the single-cell RNA-seq profiles to define relatively homogeneous differentiation stages in a 131 data-driven manner ( Fig. 2B, S9 ; Methods; Table S5 ). 132 133
Profiling multiple stages of endoderm differentiation allowed us to assess at which stage along 134 this process individual eQTL can be detected. We observed substantial regulatory and 135 transcriptional remodelling upon iPS differentiation to definitive endoderm, with over 30% of 136 eQTL being specific to a single stage ( Fig. 2A, 2C As a measure of differentiation efficiency in our experiments, we used average pseudotime 172 on day3, and observed significant variation across cell lines, which was consistent across 173 replicate differentiations of the same cell line (Fig. 3A) . Exploiting the scale of our study and 174 the pooled experimental design, we set out to identify genetic and molecular markers of 175 differentiation efficiency that are accessible prior to differentiation (Methods). 176 177
First, we considered the set of 4,422 eQTL lead variants at any of the three developmental 178 stages and tested each variant for association with differentiation efficiency ( Fig. 3B ; using a 179 linear mixed model; Methods). This identified 5 eQTL variants at a lenient false discovery rate 180 threshold (FDR 20%; Fig. 3B , Table S6 ). The most significant associations were observed 181 with eQTL variants for DPH3 (P = 3.9e-5) and H2AFY2 (P = 1e-4 Table S7 ), 15 of which were also observed when using independent bulk RNA-seq 198 data from the same cell lines (replication defined as nominal P < 0.05; Table S7; Methods).
199
As an example, the expression of ZDHHC9 in iPSCs was negatively associated with 200 differentiation efficiency (Fig. 3C) . Furthermore, ZDHHC9 is one of 17 differentiation-201 associated genes located on the X chromosome, reflecting a significant enrichment of X 202 chromosome genes (24.5-fold enrichment, P = 8x10 -16 , Fisher's exact test). Higher expression 203 of these genes was associated with reduced differentiation efficiency ( Fig. 3C; Both methods result in a measure of the varying strength of genetic effects along development, 242 or genetic effect dynamics. Reassuringly, the two approaches were highly consistent across 243 pseudotime (Fig. 4A, S10 ). 244 245
To formally test for eQTL effects that change dynamically across differentiation (dynamic 246 QTL), we tested for associations between pseudotime and the genetic effect size (defined 247 based on ASE; likelihood ratio test, considering linear and quadratic pseudotime), uncovering 248 a total of 785 time dynamic eQTL (FDR < 10%; Methods), including a substantial fraction of 249 eQTL that were not stage-specific (Table S3 ). This complements our earlier analysis, which 250 identified substantial stage-specific effects ( Fig. 2A, 2C ), by identifying subtle changes in the 251 relationship between genotype and phenotype during differentiation. To further explore this 252 set of genes, we clustered eQTL jointly based on the relative gene expression dynamics 253 (global expression changes along pseudotime, quantified in sliding windows as above, 254
Methods), and on the genetic effect dynamics ( Fig. 4A ; Methods). This identified four basic 255 dynamic patterns ( Fig. 4B ): sharply decreasing (cluster A), gradually decreasing (cluster B), 256 transiently increasing (cluster C), and gradually increasing (cluster D). As expected, stage-257 specific eQTL were grouped together in particular clusters (e.g. defendo specific eQTL in 258 cluster D; Fig. S11 ). Notably, the gene expression dynamics and the eQTL dynamics tended 259 to be distinct, demonstrating that gene expression level is not the primary mechanism 260 governing variation in genetic effects. In particular, genetic effects were not most pronounced 261 when gene expression was high (Fig. 4C, 4D ). 262 263 264 expression. This is illustrated by the mesendoderm-specific eQTL for SPP1. Overall 286 expression of SPP1 decreases during differentiation, but expression of the alternative allele is 287 repressed more quickly than that of the reference allele (Fig. 4C) . This illustrates how cis 288 regulatory sequence variation can modulates the timing of expression changes in response to 289 differentiation, similar to observations previously made in C. elegans using recombinant inbred 290 lines [19] . In other cases, the genetic effect coincides with high or low expression, for example 291 in the cases of IRF6 and AACS (Fig. 4C) . These examples illustrate how genetic variation is 292 intimately linked to the dynamics of gene regulation. 293 294 We next asked whether dynamic eQTL were located in specific regulatory regions. To do this, 295
we evaluated the overlap of the epigenetic marks defined using the hESC differentiation time 296 series with the dynamic eQTL (Fig. 4D, S12 ). This revealed an enrichment of dynamic eQTL 297 in H3K27ac, H3K4me1 (i.e. enhancer marks), and H3K4me3 (i.e. promoter) marks compared 298 to non-dynamic eQTL (i.e. eQTL that we identified but did not display dynamic changes along 299 pseudotime, Fig. 4D ), consistent with these SNPs being located in active regulatory elements. 300 301
Cellular environment modulates genetic effects on expression 302 Whilst differentiation was the main source of variation in the dataset, single cell RNA-seq 303 profiles can be used to characterize cell-toll-cell variation across a much wider range of cell 304 state dimensions [20] [21] [22] . We identified sets of genes that varied in a co-regulated manner 305 using clustering (affinity propagation; 8,000 most highly expressed genes; Table S8;  306 Methods), which identified 60 modules of co-expressed genes. The resulting modules were 307 enriched for key biological processes such as cell differentiation, cell cycle state (G1/S and 308 G2/M transitions), respiratory metabolism, and sterol biosynthesis (as defined by Gene 309 Ontology annotations; Table S9 ). These functional annotations were further supported by 310 transcription factor binding (e.g. enrichment of SMAD3 and E2F7 targets in the differentiation 311 and cell cycle modules, respectively (Table S10, S11)). Additionally, expression of the cell 312 differentiation module (cluster 6; Table S9) 
336
Using the same ASE-based interaction test as applied to identify dynamic QTL, reflecting ASE 337 variation across pseudotime ( Fig. 4; Methods) , we assessed how the genetic regulation of 338 gene expression responded to these cellular contexts. Briefly, we tested for genotype by 339 environment (GxE) interactions using a subset of four co-expression modules as markers of 340 cellular state, while accounting for pseudotime ( Fig. 5A; Methods) . These four co-expression 341 modules were annotated based on GO term enrichment, and taken as markers representing 342 cell cycle state (G1/S and G2/M transitions) and metabolic pathway activity (respiratory 343 metabolism and sterol biosynthesis; Methods). This approach extends previous work using 344 ASE to discover GxE interactions [23, 24] , taking advantage of the resolution provided by 345 single-cell data. We identified 686 eQTL that had an interaction effect with at least one factor 346 ( Fig. 5B ; FDR < 10%), with many of these effects being orthogonal to the effects of 347 differentiation. Indeed, 394 genes had no association with pseudotime, but responded to at 348 least one other factor. Conversely, of the 785 dynamic eQTL, 292 were also associated with 349 other factors, while 493 were associated only with pseudotime ( Fig. 5B, S13 5C; Methods). This identified 220 genes with significant higher order interactions between a 370 genetic variant, differentiation, and at least one other factor (Fig. 5B, 5C , S13; Table S13d ).
371
One example is the eQTL for RPS26, whose ASE was sensitive to cellular respiration, but 372 only late in differentiation (Fig. 5C) project were considered for analysis ( Table S1 ). Batches of 4-6 cell lines were co-cultured 396 and grown as a mixed population for a total of 28 experiments, in 12 well plates. Cells were 397 harvested immediately prior to the initiation of differentiation (day0; iPSCs), and at time points 398 1, 2, and 3 days post differentiation initiation (day1, day2, day3). Subsequently, single cells 399 were sorted into 384 well plates. Cells were processed using Smart-seq2 for scRNA-seq with 400 parallel FACS analysis of the markers TRA-1-60 and CXCR4 being performed for each cell. 401
A subset of cell lines were assayed in more than one experiment (33 donors; the posterior probability of a cell originating from a given donor based on common variants in 456 scRNA-seq reads, while employing a beta binomial-based Bayesian approach to account for 457 technical factors (e.g. differences in read depth, allelic drop-out, and sequencing accuracy). 458
For this assignment step, we considered a larger set of n = 490 HipSci lines with genotype 459 information, which included the 126 lines used in this study. A cell was assigned to a donor if 460 the model identified the match with posterior probability > 0.9, requiring a minimum of 10 461 informative variants for assignment. Cells for which the donor identification was not successful 462
were not considered further. Across the full dataset 99% of cells that passed RNA QC steps 463 (below) were successfully assigned to a donor. 464
scRNA-seq quality control and processing 465 Adapters of raw scRNA-seq reads were trimmed using Trim Galore! [37-39], using default 466 settings. Trimmed reads were mapped to the human reference genome build 37 using STAR 467
[40] (version: 020201) in two-pass alignment mode, using the default settings proposed by the 468 ENCODE consortium (STAR manual). Gene-level expression quantification was performed 469 using Salmon [41] (version: 0.8.2), using the "--seqBias", "--gcBias" and "VBOpt" options using 470 ENSEMBL transcripts (built 75) [42] . Transcript-level expression values were summarized at 471 a gene level (estimated counts per million (CPM)) and quality control of scRNA-seq data was 472 performed with the scater Bioconductor package in R [43] . Cells were retained for downstream 473 analyses if they had at least 50,000 counts from endogenous genes, at least 5,000 genes with 474 non-zero expression, less than 90% of counts came from the 100 highest-expressed genes, 475 less than 15% of reads mapping to mitochondrial (MT) genes, they had a Salmon mapping 476 rate of at least 60%, and if the cell was successfully assigned to a donor (Fig. S15) . Dead 477 cells as identified based on 7AAD staining were discarded. Size factor normalization of counts 478 was performed using the scran Bioconductor package in R [44] . Expressed genes with an 479 HGNC symbol were retained for analysis, where expressed genes in each batch of samples 480 were defined based on i) raw count > 100 in at least one cell prior to QC and ii) average 481 log2(CPM+1) > 1 after QC. Normalized CPM data were log transformed (log2(CPM+1)) for all 482 downstream analyses. The joint dataset was investigated for outlying cell lines or experimental 483 batches, which identified no clear groups of outlying cells (Fig. S16, S17) . 484 485
As a final QC assessment, we considered possible differences between cell lines from healthy 486 and diseased donors. In particular, a subset of 11 cell lines were derived from neonatal 487 diabetes patients, and differentiated together with cell lines from healthy donors across 7 488 experiments (out of 28). There was no detectable difference in differentiation capacity between 489 healthy and neonatal diabetes lines in these experiments (P>0.05), and cells from both sets 490 of donors overlapped in principal component space (Fig. S18) . Thus, we included cells from 491 all donors in our analyses irrespective of disease state. 492 493
The final merged and QC'ed dataset consisted of 36,044 cells with expression profiles for 494 11,231 genes (Fig. S2) . 495
Bulk RNA-Seq quality control and processing 496 Raw RNA-seq data for 546 HipSci cell-lines were obtained from the ENA project: ERP007111 497 and EGA projects: EGAS00001001137 and EGAS00001000593. CRAM files were merged 498 per cell-line and converted to FASTQ format. Processing of the merged FASTQ files was 499 matched to the single cell processing, as described above. Samples with low quality RNA-seq 500 were discarded based on the following criteria: lines with less than 2 billion bases aligned, with 501 less than 30% coding bases, or with a duplication rate higher than 75%. This resulted in 540 502 lines for analysis, 108 of which had matched (day0) single cell RNA-seq data available. 503 504
Gene-level expression levels were quantified using Salmon, analogously to the alignment, as 505 described for the single cells. Gene expression profiles were normalized using scran, to match 506 the single cell data processing, and the scran normalized CPM data is log transformed 507 (log2(CPM+1)). 508
Variance component analysis we considered a random subset of 5,000 cells. The experiment, day of collection, and cell line 512 identity were each included as random effects. Full variance component results for all genes 513 are provided in Table S14 . 514 Highly variable genes 515
The top highly variable genes were computed using scran's trendVar and decomposeVar 516 functions, using a design matrix to correct for the differentiation experiment-specific effects 517 (i.e. treating each experiment as a different batch). At FDR < 1%, this identified 4,546 highly 518 variable genes. 519
Pseudotime definition 520 We used the first principal component calculated based on the top 500 highly variable genes 521 in our set to represent differentiation pseudotime. This component was linearly re-scaled to 522 take values between 0 (the minimum value observed for any cell) and 1 (the highest value 523 observed). For comparison, we considered three alternative methods for defining pseudo time: 524 525 (i) We considered diffusion pseudotime (DPT) [46] (Fig. S7A) . The underlying diffusion map 526 was generated using 15 nearest neighbours and with gene expression represented by the first 527 20 PCs across the top 500 most highly variable genes. DPT analysis was carried out using 528 the default settings with Scanpy v1. DPT and the pseudotime definition we used. 530 531
(ii) We considered calculating pseudotime by projecting each cell on to the principal curve of 532 the first two principal components of the top 500 most highly variable genes (Fig. S7B) . 533
Principal curve analysis was performed using the R package princurve [48] . There was a 534
Pearson correlation of 0.86 between the principal curve pseudotime and the pseudotime 535 definition we used. 536 537 (iii) We considered representing pseudotime by the mean expression of the differentiation co-538 expression module. This gene cluster was enriched for GO terms associated with 539 differentiation including 'anatomical structure morphogenesis' (GO:0009653), 540 'anterior/posterior pattern specification' (GO:0009952), and 'response to BMP' (GO:0071772) 541 (Table S9 ; Fig. S7C ). There was a Pearson correlation of 0.64 between the differentiation co-542 expression module and the pseudotime definition we used. The lower concordance between 543 pseudotime and this module is consistent with the limited set of genes included -the 544 coexpression module only includes genes upregulated during differentiation, and therefore 545 uses no information from changes in expression of pluripotency-associated genes. 546 547
Definition of mesendoderm and definitive endoderm populations 548
The stage labels post iPSC (mesendo and defendo) were defined using a combination of 549 differentiation stages obtained using the single-cell defined pseudotime and knowledge based 550 on canonical marker genes. Cells were assigned to the mesendo stage if they were collected 551 at day1 or day2, and had pseudotime values between 0.15 and 0.5, corresponding to a 552 pseudotime window around the peak expression of Brachyury (T), a marker of mesendoderm 553 (Fig. S8A) . Cells were assigned to the defendo stage if they were collected at day2 or day3, 554 and had pseudotime values higher than 0.7, corresponding to a pseudotime window with 555 maximal expression of GATA6, a marker of definitive endoderm (Fig. S8B) . Cells with 556 intermediate pseudotime (between 0.5 and 0.7) mostly came from day2, and were not 557 assigned to any stage for the purposes of the initial stage QTL mapping (results shown in Fig.  558 2). Overall, we assign 28,971 (80%) cells to any of the stages (iPSC, mesendo, defendo genes with an eQTL respectively (FDR<10%). eQTL results are provided in Table S3).  632  633 For comparison, we performed analogous QTL analyses using all cells from day1, and day3 634 instead of the pseudo-time based differentiation stages. This approach resulted in 1,181 635 (10,787 tested) and 631 (10,765 tested) genes with an eQTL at day 1 and 3 respectively 636 (Table S5) . 637
Mapping dynamic eQTL (visualisation purposes only) 638 We performed eQTL mapping across a sliding window on pseudotime, considering bins that 639 contain 25% of all cells, sliding along the pseudotime by a step of 2.5% of cells (Fig. 4A, Allele-specific expression quantification 669 Duplicated reads were removed from the STAR alignments using Picard Tools 670 (http://broadinstitute.github.io/picard). ASE was quantified at the gene level relative to a 671 heterozygous eQTL lead variant. As a result, for a given eQTL, ASE was only quantified across 672 cells from donors heterozygous for that eQTL variant. This was done following five steps (see 673
Fig. S19 for a worked example of one gene in one cell): (1) ASE counts were obtained using 674 GATK tools v3.7 in ASEReadCounter mode, with the settings "-minDepth 1 --675 minMappingQuality 10 --minBaseQuality 2 -rf DuplicateRead". ASE of a SNP in a given cell 676 was quantified if (i) the cell was heterozygous for that SNP, based on the known donor 677 genotypes, and (ii) the SNP was located in an exonic region (ENSEMBL 75 annotation, as 678 above). The output from GATK tools gives the number of reads mapping to the alternative and 679 reference alleles for each heterozygous SNP in each cell. (2) For each cell, ASE 680 quantifications for each SNP were converted from "alternative allele reads" to "chrB allele 681 reads" using the known phase (indicated as chrA|chrB, where 0=reference, 1=alternative) of 682 each SNP in each donor (e.g. for a SNP with the phase "1|0", the alternative allele is on chrA, 683 so the number of reads mapping to chrB = number of reference allele reads = total number of 684 reads -number of alternative allele reads). Thus, for each cell, ASE for all SNPs was quantified 685 relative to the genotypes of the chromosomes of that individual, rather than to "reference" or 686 "alternative" alleles. (3) Aggregation of ASE from SNP-level to gene-level. For each gene, this 687 was done by summing the "chrB allele reads" and "total reads" across all SNPs contained in 688 the exons of that gene (as described in the ENSEMBL 75 GTF file). (4) Conversion of 689 quantifications from "chrB allele reads" to "reads from the chromosome containing the 690 alternative allele of the eQTL SNP", again by using the available phasing information. Five sets of tests were performed, in a linear modelling framework ( Fig. 5, S13 ; Tables S13):  708  709 (1) Linear pseudotime ("pseudo") tests. 
